SB192 - TO AMEND THE LAW CONCERNING COVERAGE OF BIOSIMLAR MEDICAL PRODUCTS UNDER STEP THERAPY PROTOCOLS; AND TO AMEND EXCEPTIONS TO STEP THERAPY PROTOCOLS.
Bill Status History
2/27/2023 4:52:54 PM
Notification that SB192 is now Act 136
2/20/2023 9:51:10 AM
DELIVERED TO GOVERNOR.
2/20/2023 9:51:05 AM
Reported correctly enrolled and ordered delivered to the Governor.
2/16/2023 2:05:18 PM
2/16/2023 2:05:14 PM
Returned from the House as passed.
2/16/2023 12:04:01 PM
Returned To the Senate as passed.
2/16/2023 12:03:55 PM
Read the third time and passed and ordered transmitted to the Senate.
2/15/2023 11:01:22 AM
Returned by the Committee Do Pass
2/8/2023 5:15:53 PM
Read the first time, rules suspended, read the second time and referred to the Committee on INSURANCE & COMMERCE- HOUSE
2/8/2023 2:36:32 PM
RECEIVED FROM THE SENATE
2/8/2023 1:35:30 PM
Ordered immediately transmitted to the House.
2/8/2023 1:35:21 PM
Read the third time and passed.
2/7/2023 1:12:12 PM
Returned by the Committee, with the recommendation that it Do Pass
2/1/2023 3:38:34 PM
Read first time, rules suspended, read second time, referred to INSURANCE & COMMERCE - SENATE
2/1/2023 3:27:34 PM